Elastrin Therapeutics

company

About

Elastrin Therapeutics is a biotech company developing novel therapies to reverse cardiovascular disease.

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$10M
Industries
Biopharma,Biotechnology,Therapeutics
Founded date
Jan 1, 2017
Number Of Employee
1 - 10
Operating Status
Active
Legal Name
Elastrin Therapeutics, Inc.

Elastrin Therapeutics is a biotech startup with technologies to restore hardened and damaged arteries & tissue by targeting the elastic fiber that makes them work.

The company's proprietary platform that targets and restores degraded elastin by removing the harmful calcification that stiffens arteries. The platform significantly improves the efficacy of drugs and eliminates side effects by combining particle design with elastin targeting.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$16.09M
Elastrin Therapeutics has raised a total of $16.09M in funding over 2 rounds. Their latest funding was raised on Apr 7, 2022 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 7, 2022 Series Unknown $10M 3 KIZOO Technology Capital Detail
Mar 25, 2022 Series Unknown $3.59M Detail
Mar 4, 2021 Seed $2.50M 1 KIZOO Technology Capital Detail

Investors

Number of Lead Investors
Number of Investors
2
3
Elastrin Therapeutics is funded by 3 investors. KIZOO Technology Capital and SC Launch, Inc. are the most recent investors.
Investor Name Lead Investor Funding Round
KIZOO Technology Capital Yes Series Unknown
SC Launch, Inc. Series Unknown
Starbloom Capital Series Unknown

Employee Profiles

Number of Employee Profiles
3
Elastrin Therapeutics has 3 current employee profiles, including Board member Patrick Burgermeister
Board member
Executive
Executive